Research, development and innovation of bioactive substances and molecules for clinical and scientific needs, turning them into higher value-added products.


Sea4Us aims to be a world-class biotechnology company in the research and development of marine pharmaceutical products.
Developing treatments for diseases without cure from Portuguese marine resources.


Sea4Us was originally created by 7 co-founders inspired by the enormous marine biodiversity of the Atlantic Ocean in Sagres, south of Portugal.
It was in this inspiring place that the Marine Station was born.

Currently, Sagres remains the main site of marine samples collection, whereas pre-clinical development is carried out in Lisbon at the Physiology Lab.

  • 2013
    Sea4Us incorporation
  • 2014
    Establishment of initial collaborations with NOVA Medical School, Câmara Municipal de vila do Bispo and Universidade do Algarve; Crowdfunding campaign
  • 2015
    Joined Bluebio Alliance as a founding member
  • 2016
    Joint-stock increase and entry of new partners
  • 2017
    Identification of bioactive analgesic molecules and mode of action; Earned 2 stamps of Excellence from the European Commission
  • 2018
    Certification in Management Systems Research, Development and Innovation according to NP4457:2007, by eiC; Second investment round; Completion of the efficacy and toxicity proof of concept
  • 2019
    Submission of two patents on one of the analgesic molecules and its mode of action